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Editorial

Non-communicable diseases: How can Homoeopathy
contribute?
Non-communicable diseases (NCDs) kill 41 million people
each year, which are equivalent to 71% of all deaths globally.
Of all NCD deaths, 77% are in low- and middle-income
countries. Cardiovascular diseases account for most NCD
deaths, or 17.9 million people annually, followed by cancers
(9.3 million), respiratory diseases (4.1 million) and diabetes
(1.5 million). These four groups of diseases account for over
80% of all premature NCD deaths.[1]
India is also a significant player in this growing burden of
NCDs. The five leading individual causes of DALYs in India,
in 2016, were ischaemic heart disease, chronic obstructive
pulmonary disease, diarrhoeal diseases, lower respiratory
infections and cerebrovascular diseases.[2]
A report based on India’s largest primary health-care survey,
covering 233,672 people and 673 public health offices in 21
states, analysed the rising cases of NCDs in the country and
the social profile of suffering households and observed that
India’s NCD burden is growing at an alarming rate with the
average age for onset falling sharply. Some of their findings
include the revelations like the prevalence of NCDs in India
which is 116/1000 population, which shows a quantum jump
among individuals above 35 years of age. Environmental
factors are the most significant cause of NCDs, followed by
inactive lifestyle, imbalanced diet, intoxication (alcohol and
tobacco consumption) and leisure lifestyle.[3] NCDs affect both
rural and urban populations, although the factors influencing
these NCDs are different in these populations.[4]
The battle against NCDs is a tough one, but not insurmountable
if the symptoms are detected early. It is imperative to prevent
and control risk factors in an integrated manner by developing
strategies and policies to inhibit the NCD burden on the country.
To prevent and control major NCDs, the National Programme
for Prevention and Control of Cancer, Diabetes, Cardiovascular
Diseases and Stroke (NPCDCS) was launched by the Government
of India in 2010 with a focus on strengthening infrastructure,
human resource development, health promotion, early diagnosis,
management and referral.[5] Under this programme, a pilot project
on ‘Integration of AYUSH with NPCDCS’ was initiated in 2015
in six districts in the country, whereby AYUSH facilities and
methodologies were integrated with NPCDCS services for the
prevention and management of common NCDs. The practice of
Yoga was an integral part of the intervention, along with any one
of the Ayurveda, Unani, Siddha or Homoeopathy intervention.
[6]
The pilot project ended in 2021. In the homoeopathy adopted
districts, approximately 200,000 populations were screened.
Of these, 55% reported one of the NCDs targeted in the
NPCDCS program. Prehypertension or high normal blood
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pressure, hypertension, pre-diabetes and diabetes accounted for
a significant portion, that is, 78%, while multimorbidity, that is,
suffering from more than two chronic conditions, covered 22%
of the disease burden. Integration of homoeopathy along with
Yoga leads to behavioural changes towards a healthy lifestyle,
improvement in outcomes related to daily living and reduction
in the severity of day-to-day health-related complaints.
There are limited studies which support the role of Homoeopathy
in NCDs, such as hypertriglyceridemia, diabetes mellitus,
hypertension, cancers, stroke and related problems. [7-12]
Systematic well-designed pragmatic controlled trials are the
next step to generate more evidence in a real-world practice
maximizing external validity by studying interventions in the
context of routine clinical practice conditions for establishing
effectiveness in these multifaced NCDs.[13]
Moreover, a conscious effort needs to be made to reduce
sedentary lifestyle, break unhealthy habits like low physical
activity and unhealthy food habits that have become integral
aspects of modern-day lifestyle and have been found to have
the most significant role in causing NCDs.
In this issue, a narrative review explores the strengths of
homoeopathy in the management of chronic kidney disease
through pre-clinical, clinical and anecdotal evidence throwing
light on the need for well-designed studies. [14] A drug
standardisation study compares the in-house homoeopathic
mother tincture and market samples of Hydrocotyle asiatica
by evaluating their antioxidant activity and high-performance
thin-layer chromatography study.[15] Another in vitro study
reported in this issue, which analyses the anti-cholesterol
activity of homoeopathic medicine Colchicum autumnale on
cholesterol level of blood.[16] Two evidence-based case reports
of homoeopathic management of nephrotic syndrome, and multimorbid gynaecological complaints are also reported.[17,18] A case
series demonstrates the homoeopathic management of polycystic
ovarian syndrome that is also presented in this issue.[19]
The homoeopathic fraternity is deeply saddened by the demise
of Dr. Girendra Pal who would be remembered for his valued
contributions to homoeopathy.[20]
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